🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The study is being conducted to evaluation of the Efficacy and Safety of QL...
Status
Recruiting
Location
Shanghai Chest Hospital
Start Date
2025-10-23
Trial ID
NCT07091305
Treatments Being Tested
This phase I/II study is to evaluate the recommended dose, safety, feasibil...
Status
Active Not Recruiting
Location
Aerospace Center Hospital, Peking University Aerospace School of Clinical Medicine
Start Date
2025-03-17
Trial ID
NCT06809530
Treatments Being Tested
This study is to evaluate the efficacy and safety of QL1706 plus albumin-bo...
Status
Recruiting
Location
Fudan University Shanghai Cancer Center
Start Date
2024-10-09
Trial ID
NCT06786026
Treatments Being Tested
The goal of this clinical trial is to learn if QL1706 is effective in early...
Status
Recruiting
Location
Henan cancer hospital
Start Date
2025-09-08
Trial ID
NCT06967103
This study will evaluate the efficacy and safety of cryoablation combined w...
Status
Recruiting
Location
Zhongshan Hospital, Fudan University
Start Date
2025-08-20
Trial ID
NCT07070700
Treatments Being Tested
To explore the efficacy and safety of administrating QL1706 in patients wit...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-10-01
Trial ID
NCT07141186
Treatments Being Tested
This study will look at the efficacy and safety of QL1706 plus albumin-boun...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-05-06
Trial ID
NCT06404463
This study will look at the efficacy and safety of QL1706 plus albumin-boun...
Status
Not Yet Recruiting
Location
Zhimin Shao
Start Date
2024-05-07
Trial ID
NCT06404736
Treatments Being Tested
The purpose of this study is to assess the efficacy and safety of QL1706 pl...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-01
Trial ID
NCT06746961
Treatments Being Tested
Triple-negative breast cancer (TNBC) accounts for about 20% of breast cance...
Status
Recruiting
Location
Xijing hospital
Start Date
2025-11-06
Trial ID
NCT07178171